Genosco Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • M&A
  • (Upcoming)

  • Financing Rounds
  • 5

Genosco General Information

Description

Operator of a biotechnology firm intended to discover and develop novel small-molecule drugs. The company specializes in medicinal chemistry, structural and computational drug discovery design, cell biology, pharmacology, and drug metabolism, providing patients with medications required to treat their illness.

Contact Information

Website
www.genosco.com
Formerly Known As
OCT USA
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 43 Manning Road
  • Billerica, MA 01821
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 43 Manning Road
  • Billerica, MA 01821
  • United States
+1 (617)

Genosco Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genosco Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genosco‘s full profile, request access.

Request a free trial

Genosco Patents

Genosco Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260109702-A1 Novel gspt protein degrader and application thereof Pending 17-Oct-2024
WO-2026085513-A1 Novel gspt protein degrader and application thereof Pending 17-Oct-2024
AU-2024258861-A1 Blood brain barrier penetrating selective inhibitors of rock2 protein kinases and uses thereof Pending 18-Apr-2023
EP-4698529-A1 Blood brain barrier penetrating selective inhibitors of rock2 protein kinases and uses thereof Pending 18-Apr-2023
US-20240360139-A1 Blood brain barrier penetrating selective inhibitors of rock2 protein kinases and uses thereof Pending 18-Apr-2023 C07D405/14
To view Genosco’s complete patent history, request access »

Genosco Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genosco Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genosco‘s full profile, request access.

Request a free trial

Genosco FAQs

  • When was Genosco founded?

    Genosco was founded in 2000.

  • Where is Genosco headquartered?

    Genosco is headquartered in Billerica, MA.

  • What is the size of Genosco?

    Genosco has 32 total employees.

  • What industry is Genosco in?

    Genosco’s primary industry is Drug Discovery.

  • Is Genosco a private or public company?

    Genosco is a Private company.

  • What is Genosco’s current revenue?

    The current revenue for Genosco is .

  • How much funding has Genosco raised over time?

    Genosco has raised $13.2M.

  • Who are Genosco’s investors?

    Forward Equity Partners, Meritz Securities, and Yuhan have invested in Genosco.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process